The diagnostic value of FDG and amyloid PET in Alzheimer's disease—A systematic review

L Rice, S Bisdas - European journal of radiology, 2017 - Elsevier
Purpose By 2050 it is projected that 115 million people worldwide will have Alzheimer's
Disease (AD)[1]. Recent attempts have been made to redefine the diagnostic criteria of AD …
被引用次数：155 相关文章

The diagnostic value of FDG and amyloid PET in Alzheimer's disease—A systematic review

L Rice, S Bisdas - European Journal of Radiology, 2017 - ejradiology.com
Purpose By 2050 it is projected that 115 million people worldwide will have Alzheimer's
Disease (AD)[1]. Recent attempts have been made to redefine the diagnostic criteria of AD …

The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review

L Rice, S Bisdas - European journal of radiology, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose By 2050 it is projected that 115 million people worldwide will have Alzheimer's
Disease (AD)[1]. Recent attempts have been made to redefine the diagnostic criteria of AD …

The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review.

L Rice, S Bisdas - European Journal of Radiology, 2017 - europepmc.org
Purpose By 2050 it is projected that 115 million people worldwide will have Alzheimer's
Disease (AD)[1]. Recent attempts have been made to redefine the diagnostic criteria of AD …

[引用][C] The diagnostic value of FDG and amyloid PET in Alzheimer's disease—A systematic review

L Rice, S Bisdas - European Journal of Radiology, 2017 - cir.nii.ac.jp
The diagnostic value of FDG and amyloid PET in Alzheimer’s disease—A systematic review |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

The diagnostic value of FDG and amyloid PET in Alzheimer's disease—A systematic review

L Rice, S Bisdas - European Journal of Radiology, 2017 - inis.iaea.org
[en] Highlights:• Systematic review of 60 papers from 2001 to 2017.• Highlights the
importance of accurate imaging biomarkers in AD in improving diagnostic accuracy …